FR2113243A5 - - Google Patents

Info

Publication number
FR2113243A5
FR2113243A5 FR7138383A FR7138383A FR2113243A5 FR 2113243 A5 FR2113243 A5 FR 2113243A5 FR 7138383 A FR7138383 A FR 7138383A FR 7138383 A FR7138383 A FR 7138383A FR 2113243 A5 FR2113243 A5 FR 2113243A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7138383A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of FR2113243A5 publication Critical patent/FR2113243A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7138383A 1970-10-30 1971-10-26 Expired FR2113243A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5179270 1970-10-30

Publications (1)

Publication Number Publication Date
FR2113243A5 true FR2113243A5 (enExample) 1972-06-23

Family

ID=10461392

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7138383A Expired FR2113243A5 (enExample) 1970-10-30 1971-10-26

Country Status (5)

Country Link
DE (1) DE2154050A1 (enExample)
DK (1) DK130836B (enExample)
FR (1) FR2113243A5 (enExample)
GB (1) GB1353598A (enExample)
NL (1) NL7114743A (enExample)

Also Published As

Publication number Publication date
NL7114743A (enExample) 1972-05-03
DE2154050A1 (de) 1972-05-04
GB1353598A (en) 1974-05-22
DK130836B (da) 1975-04-21
DK130836C (enExample) 1975-11-03

Similar Documents

Publication Publication Date Title
AR204384A1 (enExample)
ATA96471A (enExample)
AU2044470A (enExample)
AU1146470A (enExample)
AU1473870A (enExample)
AU2085370A (enExample)
AU1336970A (enExample)
AU2130570A (enExample)
AU2017870A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1517670A (enExample)
AU1326870A (enExample)
AR195465A1 (enExample)
AU1591370A (enExample)
AU1841070A (enExample)
AU1328670A (enExample)
AU2144270A (enExample)
AU1343870A (enExample)
AU1277070A (enExample)
AU2131570A (enExample)
AU2130770A (enExample)
AU1247570A (enExample)
AU1581370A (enExample)
AU1235770A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse